AmerisourceBer…
ProfileJobs (544)

AmerisourceBergen

Suggest Edit
    • Healthcareclinicshospitalspharmasenior care
    AmerisourceBergen is one of the world's largest pharmaceutical services companies serving global markets with a focus on the pharmaceutical supply chain. Servicing both pharmaceutical manufacturers and healthcare providers, The Company provides drug distribution and related services designed to reduce costs and improve patient outcomes.
    Revenue(FY, 2017)
    $153.1 B
    Market capitalization(2018-10-15)
    $19.4 B
    TypePublic
    HQChesterbrook, US
    Founded2001
    Size (employees)20,000 (est)+12%
    Websiteamerisourcebergen.com
    AmerisourceBergen was founded in 2001 and is headquartered in Chesterbrook, US
    Report incorrect company information

    Viewing summary data as a guest

    Sign up for free to see all data

    Key People/Management at AmerisourceBergen

    Steven Collis

    Steven Collis

    Chairman, President and Chief Executive Officer
    Kathy Gaddes

    Kathy Gaddes

    Executive Vice President and Chief Human Resources Officer
    Albert Morales

    Albert Morales

    Chief Transformation Officer
    Tim Guttman

    Tim Guttman

    Executive Vice President and Chief Financial Officer
    John Chou

    John Chou

    Executive Vice President and Chief Legal & Business Officer
    Gina Clark

    Gina Clark

    Executive Vice President and Chief Communications & Administration Officer
    Show more

    AmerisourceBergen Office Locations

    AmerisourceBergen has an office in Chesterbrook
    Chesterbrook, US (HQ)
    1300 Morris Dr
    Show all (1)
    Report incorrect company information

    AmerisourceBergen Financials and Metrics

    AmerisourceBergen Revenue

    Embed Graph
    AmerisourceBergen's revenue was reported to be $153.14 b in FY, 2017 which is a 4.3% increase from the previous period.
    USD

    Revenue (Q3, 2018)

    		124.6b

    Gross profit (Q3, 2018)

    		3.6b

    Gross profit margin (Q3, 2018), %

    		2.9%

    Net income (Q3, 2018)

    		1.4b

    EBIT (Q3, 2018)

    		1.3b

    Market capitalization (15-Oct-2018)

    		19.4b

    Closing stock price (15-Oct-2018)

    		89.5

    Cash (30-Jun-2018)

    		2.4b

    EV

    		21.2b
    AmerisourceBergen's current market capitalization is $19.4 b.
    Annual
    USDFY, 2014FY, 2015FY, 2016FY, 2017

    Revenue

    		119.6b136.0b146.8b153.1b

    Revenue growth, %

    		36%14%8%4%

    Cost of goods sold

    		116.6b132.4b142.6b148.6b

    Gross profit

    		3.0b3.5b4.3b4.5b
    Quarterly
    USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q2, 2018Q3, 2018

    Revenue

    		29.2b28.5b30.3b33.6b32.7b34.2b36.7b35.7b36.9b38.2b37.1b38.7b81.5b124.6b

    Cost of goods sold

    		28.5b27.7b29.7b32.8b31.8b33.3b35.7b34.6b35.8b37.1b35.9b37.6b79.1b121.1b

    Gross profit

    		688.2m729.6m692.0m752.3m912.0m891.5m964.9m1.1b1.1b1.0b1.3b1.1b2.4b3.6b

    Gross profit Margin, %

    		2%3%2%2%3%3%3%3%3%3%3%3%3%3%
    show all
    Annual
    USDFY, 2014FY, 2015FY, 2016FY, 2017

    Cash

    		1.8b2.2b2.7b2.4b

    Accounts Receivable

    		(1.3b)

    Current Assets

    		16.8b20.3b22.9b24.3b

    PP&E

    		899.6m979.3m1.5b1.8b
    Quarterly
    USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q2, 2018Q3, 2018

    Cash

    		347.5m696.7m1.3b2.3b2.3b2.6b978.1m2.5b1.9b1.8b2.4b1.3b2.1b2.4b

    Current Assets

    		15.2b15.8b15.9b20.1b19.6b19.9b20.4b22.1b21.5b23.1b23.5b23.7b26.4b26.4b

    PP&E

    		824.1m850.8m882.2m907.0m955.6m958.7m1.1b1.1b1.2b1.6b1.7b1.7b1.9b1.9b

    Goodwill

    		6.0b6.0b6.0b6.7b6.7b
    show all
    Annual
    USDFY, 2014FY, 2015FY, 2016FY, 2017

    Net Income

    		276.5m(134.9m)145.7b364.5m

    Depreciation and Amortization

    		237.1b

    Accounts Payable

    		2.3b5.1b3.0b1.5b

    Cash From Operating Activities

    		1.5b3.9b3.2b1.5b
    Quarterly
    USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q2, 2018Q3, 2018

    Net Income

    		41.4m221.5m208.7m(199.9m)(713.3m)(499.2m)330.4m934.5m1.3b247.2m658.7m709.1m1.1b1.4b

    Accounts Payable

    		247.8m351.0m877.0m384.4m463.9m

    Cash From Operating Activities

    		(1.0b)112.7m632.5m897.0m1.6b2.8b750.8m1.6b1.8b(430.4m)368.4m123.7m(77.2m)746.0m

    Cash From Investing Activities

    		(68.2m)(128.1m)(319.2m)(77.2m)(2.7b)(2.7b)(2.8b)(2.9b)(3.0b)(156.9m)(269.5m)(406.6m)(935.4m)(1.0b)
    show all
    USDY, 2018

    EV/EBIT

    		16.4 x

    EV/CFO

    		28.4 x

    EV/FCF

    		42.6 x

    Financial Leverage

    		11.7 x
    Show all financial metrics

    AmerisourceBergen Operating Metrics

    FY, 2016

    Countries

    		50

    Distribution Centers

    		26
    Show all operating metrics

    AmerisourceBergen Acquisitions / Subsidiaries

    Acquired CompanyDateDeal Size
    MWI Veterinary SupplyJanuary 12, 2015$2.50 b
    TheraComDecember 31, 2011$250 m
    IntrinsiQSeptember 06, 2011$35 m

    AmerisourceBergen Revenue Breakdown

    Embed Graph

    AmerisourceBergen revenue breakdown by business segment: 95.7% from Pharmaceutical Distribution and 4.3% from Other

    Report incorrect company information

    Competitors

    McKesson
    Healthcare - Public
    Cardinal Health
    Healthcare - Public
    Henry Schein
    Healthcare - Public
    Owens & Minor
    Healthcare - Public
    Compare competitors

    AmerisourceBergen Online and Social Media Presence

    Embed Graph
    Report incorrect company information

    AmerisourceBergen News and Updates

    October 04, 2018

    Scott+Scott Attorneys at Law LLP Investigating Derivative Claims on Behalf of Shareholders of AmerisourceBergen Corporation - ABC

    NEW YORK, Oct. 4, 2018 /PRNewswire/ -- Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, is investigating whether certain directors and officers of AmerisourceBergen Corporation ("AmerisourceBergen" or the "Company") (NYSE: ABC)...
    October 01, 2018

    Former AmerisourceBergen Executive Blows the Whistle on Massive Drug Overfill Laundering Scheme, Leading to $885 Million Combined Civil and Criminal Settlement

    WASHINGTON, Oct. 1, 2018 /PRNewswire/ -- Whistleblower Law Collaborative and Kellogg, Hansen, Todd, Figel & Frederick, P.L.L.C. report Michael Mullen, the former chief operating officer of a subsidiary of AmerisourceBergen Corporation (NYSE: ABC), played an instrumental role in a landmark ...
    October 01, 2018

    AmerisourceBergen in $625 mln drug distribution settlement, New York says

    AmerisourceBergen Corp will pay the U.S. government and various states $625 million to resolve claims over the illegal distribution of adulterated and misbranded drugs, New York Attorney General Barbara Underwood said on Monday.
    August 22, 2018

    AmerisourceBergen CEO Says Getting Employees to Think Big is Key to Success

    Bold acquisitions and global expansion lifted Amerisource's ranking to number 12 on Fortune 500
    August 08, 2018

    Netskope Names AmerisourceBergen Winner of Cloud Security Excellence Award

    LOS ALTOS, Calif., Aug. 8, 2018 /PRNewswire/ -- Netskope, the leader in cloud security, today named pharmaceutical company and Fortune 20 member AmerisourceBergen as the winner of the inaugural Cloud Security Excellence Award, recognizing the organization's commitment to secure cloud...
    August 06, 2018

    Christian Herrington, Veteran Pharmaceutical Business Executive, Joins HealthGrowth Capital's Advisory Board

    AUSTIN, Texas, Aug. 6, 2018 /PRNewswire/ -- HealthGrowth Capital LLC, a leading alternative specialty lender to independent pharmacies and healthcare companies, is pleased to announce the appointment of Christian Herrington to the Company's Board of Advisors. "We are excited to welcome...
    Show more
    Report incorrect company information

    AmerisourceBergen Company Life and Culture

    Report incorrect company information
    Download PDF